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Objectives: Neurological soft signs (NSS), i.e., minor motor and sensory changes, are a
common feature in severe psychiatric disorders. We sought to establish the frequency
of NSS in patients with mild cognitive impairment (MCI) and Alzheimer’s disease (AD) on
basis of a large population-based sample and to identify their neuropsychological correlates
including cognitive reserve.
Methods: Neurological soft signs were examined using an abbreviated version of the Hei-
delberg NSS Scale in 221 “old” participants born between 1930 and 1932 (63 with MCI,
15 with AD, 143 healthy old controls) and 256 healthy “young” participants (born between
1950 and 1952) of the population-based interdisciplinary longitudinal study of aging. Sub-
jects received thorough neuropsychological testing; years of school education were used
as a proxy for cognitive reserve.
Results: Neurological soft signs scores were significantly (p<0.001) higher in the AD
patients (5.6±3.11) than in the healthy old controls (2.8±1.90) and in the MCI patients
(3.0±1.96).This result was confirmed after years of school education, which were inversely
correlated (r =−0.25; p<0.001) with NSS were entered as a covariate. In the patients, but
not in the controls, NSS were significantly correlated with deficits in executive function-
ing and visuospatial functioning. Comparison of NSS scores between “old” (2.84±1.9)
and “young” (2.46±1.97) controls yielded only minor, non-significant differences after
education (13.86±3.0 vs. 14.61±2.48 years, respectively) was controlled for.
Conclusion: Our results demonstrate that NSS are frequently found in mild AD, but not
in MCI. NSS refer to frontal-executive deficits and visuospatial dysfunction rather than age
per se and can be partly compensated for by cognitive reserve.
Keywords: NSS, MCI, AD, cognitive reserve, ILSE
INTRODUCTION
Recent studies (1, 2) demonstrate that neurological soft signs
(NSS) – i.e., minor motor and sensory deficits – are frequently
found in Alzheimer’s disease (AD) and mild cognitive impair-
ment (MCI) as they were consistently described in other major
psychiatric conditions such as bipolar disorder or especially schiz-
ophrenia (3, 4). Corresponding to the significant association found
between NSS and negative symptoms in schizophrenia (5) and
Seidl et al. (2) reported a significant correlation between NSS
and apathy in a large group of nursing home residents (n= 120)
with mild to severe AD. Similar to earlier reports in schizophre-
nia [reviewed in Ref. (6)], Seidl et al. (2) did not find NSS to be
associated with neuroleptic treatment. However, other important
aspects of NSS known from studies in schizophrenia – in par-
ticular, the associations of NSS with neuropsychological deficits
(7–10) – were not yet tested in AD. This question is of particu-
lar importance as positive effects of physical activity on cognitive
performance are generally accepted (11).
It is generally accepted that high levels of physical activity are
associated with a reduced risk for developing AD potentially by
facilitating the brain and cognitive reserve. Another study of our
group (11) investigated muscular strength as measured by a vig-
orimeter and motor coordination, which was operationalized by
means of the one-foot-standing test, with respect to the risk of
developing MCI or AD in the interdisciplinary longitudinal study
of aging (ILSE). In the framework of this prospective population-
based study, subjects (born 1930–1932) were examined at three
examination waves (t 1:1993/1994; t 2: 1997/1998; t 3: 2005/2007).
The study demonstrated that motor coordination evaluated at t 1
but not muscular strength was a significant predictor of cognitive
impairment at t 3.
Another important question refers to the nature of NSS as signs
of generalized rather than discrete cerebral changes. Along with
this, neuroimaging studies in schizophrenia identified a number of
dispersed cerebral sites associated with NSS (12–15). Hence, one
may expect to find increased NSS scores in manifest AD where
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cerebral changes involve large parts of the brain rather than in
MCI where cerebral changes still remain localized in the medial
temporal lobe. Accordingly, NSS scores should be rather stable in
the process of healthy aging since the latter does not involve major
cerebral changes.
We therefore thought to investigate NSS with respect to neu-
ropsychological deficits and school education, as a proxy of cogni-
tive reserve and to compare NSS scores between patients with MCI
or AD and healthy old controls. In addition, NSS scores obtained in
the latter were compared with scores measured in young controls
to identify age-related changes.
MATERIALS AND METHODS
PARTICIPANTS
The ILSE-study is based on two birth cohorts born during 1930–
1932 and 1950–1952 who were randomly recruited according to
community registers in the urban regions of Leipzig (Saxony) and
Heidelberg/Mannheim (Palatine). The study was approved by the
ethical committee of the University of Heidelberg and written
informed consent after complete description of the study to the
subjects was obtained. The first examinations took place between
December 1993 and January 1996. Data of the present study cor-
respond to the third examination wave, which were performed
between 2005 and 2008, i.e., more than 12 years after the initiation
of the study. At this time, 381 participants of the 1930–1932 cohort
and 408 participants of the 1950–1952 – corresponding to more
than 75 and 80%, respectively, of the original cohorts – could
be reinvestigated. Participants with a current episode of major
depression, substance abuse, anxiety disorder, bipolar disorder,
schizophrenia, or meeting ICD 10 criteria for a cognitive disorder
due to a general medical condition were excluded from the analysis
since these conditions usually course with both neurological signs
and cognitive deficits and may overlap with dementia. Hence, a
sample of 477 participants was available for analyses comprising
256 participants of the 1950–1952 cohort and 221 participants of
the 1930–1932 cohort.
Sixty-three participants out of 221 (28.51%) were diagnosed
with MCI and 15 with AD (6.79%) in the 1930–1932 cohort.
Because we were interested in investigating the effects of age on
NSS performance 256 otherwise healthy participants from the
young cohort were also included. Hence, three groups were con-
stituted: healthy young controls, (n= 256), healthy old controls
(n= 143) old-aged with MCI (MCI; n= 63), and old-aged with
AD (AD; n= 15). All participants selected for the present study
had complete core data sets (socio-demographic variables, diag-
noses, NSS), while the thorough neuropsychological test battery
could be completed in the whole group. The mini-mental state
examination [MMSE, (16)] was not applied in the young cohort.
SURVEY MEASURES
All participants were carefully screened for physical and men-
tal health by extensive clinical interviews, physical examinations,
laboratory tests, and a thorough assessment of neuropsycholog-
ical functioning. Cognitive assessment included the MMSE and
subtests of the Nürnberger-Alters-Inventar [NAI, (17)] and the
Leistungsprüfsystem (18), both of which are well-established and
commonly used test batteries in Germany [for more details, see
Ref. (19)]. Subjective cognitive complaints were assessed by inter-
viewing and applying the respective items of the Nürnberger
Selbsteinschätzungsliste [NSL; (20)].
Neurological soft signs were examined by using the modified
version (2) of the Heidelberg Neurological Soft Signs Scale (4),
which included five items, named – (a) finger-to-nose movement,
(b) diadochokinesia, (c) pronation and supination, (d) finger-
thumb opposition, and (e) mirror movements. The scores of the
items were scaled from 0 (no prevalence) to 3 (marked prevalence),
with a total score of maximum 18. The subtests were selected from
the original scale based upon clinical and research experience col-
lected with demented patients. Examination subtest had to be easy
to understand by AD patients.
PSYCHIATRIC DIAGNOSES
Clinical axis I diagnoses were obtained by using the German ver-
sion of the Structured Clinical Interview for the DSM-III-R [SKID
I, (21)]. MCI was defined by using the aging-associated cognitive
decline (AACD) criteria, which were already applied in the first
two examination waves (19, 22). Diagnostic criteria for AACD
have been proposed by the international psychogeriatric associ-
ation (23) and include (1) subjective impairment: a report by
the individual (or a reliable informant) that cognitive function
has declined and (2) objective impairment in any of the follow-
ing cognitive domains, as indicated by a neuropsychological test
performance of at least 1 SD below normal age and educational
levels: memory and learning, attention and concentration, abstract
thinking (problem solving, abstraction), language, and visuospa-
tial functioning. AD was diagnosed according to the NINCDS–
ADRA (24). All diagnoses were confirmed by both specialists in
old age psychiatry involved.
STATISTICAL ANALYSES
Clinical variables, NSS, and neuropsychological performances
were compared between groups by calculating separate analyses
of covariance (ANCOVA) with group (healthy young controls
vs. healthy old controls vs. MCI vs. AD) as predictor variable
and years of education as covariate. Post hoc comparison analyses
were based on Duncan’s test. The potential relations between NSS,
clinical variables, and neuropsychological findings were addressed
by calculating Pearson product-moment correlation coefficients,
which were controlled for years of education. All computations
were performed by using the 9.2 version of the SAS Software.
RESULTS
The clinical characteristics, neuropsychological performance, and
total NSS scores obtained in the diagnostic groups are summa-
rized in Table 1. Diagnostic groups differed significantly with
respect to age and years of school education but showed no sig-
nificant differences in sex distribution. As expected, AD patients
scored significantly lower than MCI patients, followed by healthy
old controls, on the MMSE. With respect to neuropsychological
test performance, three patterns of group differences arose: per-
formance on verbal memory, digit symbol, D2, and visuospatial
thinking tests conformed to the expected order with the highest
scores achieved by healthy young controls, followed by healthy
old controls and MCI, and the lowest scores obtained by AD.
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Table 1 | Demographic and neuropsychological characteristics by subgroup with the results of a Duncan test at the 5%-level.
Healthy young
controls
(n=256)
Healthy old
controls
(n=143)
MCI (n=63) AD (n=15) F (df) p Duncan/Chi Square
DEMOGRAPHICS
Age 55.15 (0.97) 73.94 (0.99) 74.21 (1.03) 74.73 (1.03) 14525 (3, 473) <0.001 HY<HO=OMCI=OAD
Sex (women/men) 126/130 75/68 32/31 7/8 n.a. n.s. Chi-Sq: 0.469
Education 14.61 (2.48) 13.86 (2.99) 12.22 (2.41) 11.20 (1.78) 20.07 (3, 473) <0.001 HY=HO>OMCI=OAD
MMSE (n=218) n.a. 28.91 (1.12) 28.07 (1.41) 24.13 (2.39) 90.02 (2, 215) <0.001 HO>OMCI>OAD
NEUROPSYCHOLOGY
Verbal memory: immediate
recall (n=438)
14.59 (3.16) 12.36 (3.47) 10.35 (3.46) 7.5 (3.50) 31.7 (3, 434) <0.001 HY>HO>OMCI>OAD
Verbal memory: delayed
recognition (n=438)
7.93 (2.27) 6.91 (2.35) 5.81 (2.50) 4.0 (2.63) 14.5 (3, 434) <0.001 HY=HO>OMCI>OAD
DST (n=438) 53.94 (9.33) 44.15 (9.51) 36.11 (8.73) 25.8 (8.94) 72.4 (3, 434) <0.001 HY>HO>OMCI>OAD
D2 (n=432) 164.45 (32.06) 136.79 (33.08) 105.67 (33.93) 76.67 (43.37) 50.1 (3, 428) <0.001 HY>HO>OMCI>OAD
Finding similarities (n=439) 26.64 (4.17) 26.77 (4.07) 22.6 (6.27) 16.0 (6.62) 18.1 (3, 435) <0.001 HY=HO>OMCI>OAD
Verbal fluency (n=439) 32.38 (9.36) 32.15 (8.23) 24.47 (8.48) 18.8 (8.9) 11.0 (3, 435) <0.001 HY=HO>OMCI>OAD
Visuospatial thinking (n=437) 25.41 (6.04) 21.79 (5.72) 17.53 (7.41) 11.56 (6.93) 24.2 (3, 433) <0.001 HY>HO>OMCI>OAD
NSS 2.46 (1.97) 2.84 (1.91) 3.0 (1.96) 5.6 (3.11) 8.0 (3, 473) <0.001 HY=HO=OMCI<OAD
MCI, mild cognitive impairment; AD, Alzheimer’s disease; MMSE, mini-mental state examination; DST, digit symbol test; D2, D2-test; NSS, neurological soft signs;
n.a., not applicable; n.s., not significant.
In the subtests, verbal memory recognition, verbal fluency, and
finding similarities, significant group differences were found only
between MCI and AD, while healthy young controls and healthy
old controls showed similar results. AD patients demonstrated
significantly more NSS compared to the other three subgroups.
As demonstrated in Figure 1 across all diagnostic groups, NSS
scores were inversely correlated with years of school education
(r =−0.25; p< 0.001). The ANCOVA with years of school edu-
cation as a covariate [F(4,472)= 15.78, p< 0.0001] yielded a
significant main effect (type III ss) of diagnostic group on NSS
scores [F(3,473)= 7.95, p< 0.0001].
To further analyze the correlations between NSS and neuropsy-
chology deficits, the subgroups of patients with MCI and AD were
collapsed. Within this joint group of cognitively impaired, NSS
scores were significantly inversely correlated with scores on the
MMSE, on the DST, and on the tests for visuospatial function-
ing and verbal fluency, processing speed, and cognitive flexibility,
respectively (Table 2).
DISCUSSION
The main findings of the present study can be summarized as fol-
lows: significantly increased NSS scores (i) were found in patients
with AD but not in patients with MCI or healthy old controls
compared to healthy young controls, (ii) correspond to deficient
executive functioning and visuospatial apraxia and can be par-
tially compensated for by cognitive reserve, and (iii), are not the
sequelae of aging per se.
The present study confirmed increased NSS scores in patients
with mild AD as previously described by a number of studies (2,
25, 26), which also examined patients in more advanced stages of
the disease. This increase was not observed patients with MCI.
In contrast, Li et al. (1) reported significantly increased NSS
FIGURE 1 | NSS and years of education across diagnostic subgroups.
NSS, neurological soft signs; HO, healthy old controls; HY, healthy young
controls; MCI, patients with MCI; AD, patients with Alzheimer’s disease.
scores – which particularly involved motor coordination signs –
in 29 MCI patients who were compared with 28 healthy controls.
This discrepancy might refer to methodological differences, such
as sample size and mode of recruitment, as well as the rela-
tively greater severity of cognitive deficits in their MCI group,
in particular (mean MMSE scores: 26.07± 2.33 vs. 28.07± 1.41,
respectively).
Similar to the study of Chan et al. (27), NSS scores were
significantly correlated with neuropsychological deficits involv-
ing executive functioning (verbal fluency, digit symbol test) and
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Table 2 | Neuropsychological correlates of NSS in patients with MCI or AD.
NP-test MMSE Verbal memory
(immediate recall)
Verbal memory
(delayed recognition)
DST D2-test Finding
similarities
Verbal
fluency
Visuospatial
thinking
NSS
r uncorrected
(corrected)
r =−0.45** r =−0.08
(r =−0.04)
r =−0.03
(r =−0.03)
r =−0.37*
(r =−0.39*)
r =−0.13
(r =−0.15)
r =−0.21
(r =−0.18)
r =−0.37*
(r =−0.37*)
r =−0.41**
(r =−0.36*)
Values corrected for education in brackets. Bold font indicates significant correlations.
NP, neuropsychology; MCI, mild cognitive impairment; AD, Alzheimer’s disease; MMSE, mini-mental state examination; DST, digit symbol test; D2, D2-test;
NSS, neurological soft signs.
*p<0,005; **p<0.001.
visuospatial thinking. Verbal memory was not associated with
NSS. In the light of these findings, the significant correlation of
NSS and logical memory reported by Chan et al. (27) may refer to
the fact that the latter also involves some aspects of executive func-
tioning in the sense of mnestic strategies. It is notable that similar
associations between NSS and executive deficits were also reported
in schizophrenia [for review see Ref. (7)] and in HIV associated
neurocognitive disorders (28). That motor performance in AD is
related to executive functioning is further supported by the results
of dual-task studies, which even yielded interactions between fall
risk and executive dysfunctions (29–32).
In all subgroups under investigation, NSS were inversely related
with years of school education as a marker of cognitive reserve.
This association corresponded to a wealth of studies [for review
see Ref. (11)], which identified motor abilities to be a protective
factor for cognitive decline and could be mediated by the benefi-
cial effects of aerobic exercise on the hippocampus (33) and the
frontal cortices (34).
Despite the large sample size, a comparison of NSS scores
between healthy young controls and healthy old controls yielded
only minor, non-significant differences. In contrast, Chan et al.
(27) who examined 180 subjects aged 60–96 suggested that NSS
were very common among the elderly. Their study, however, dif-
fers with respect to a variety of important methodological details
from the present investigation, among them the definition of cog-
nitively intact controls by a MMSE score of >24. This definition
may well have led to the inclusion of patients with mild AD who
often showed MMSE scores up to 26. Along with this, educational
levels were in the range of 6.8± 4.4 years and do not compare
with the respective value found in our sample. Similarly, Kodama
et al. (35) found deficits in diadochokinesis, finger-to-nose test,
and tandem gate to increase with age in 348 subjects aged 60–89.
However, educational level and MMSE scores were considerably
lower than in our birth cohorts rendering a direct comparison
of the results difficult. Therefore, our finding only applies to the
rather “young” old investigated here and needs to be confirmed
in the further course of the ILSE when subjects have reached a
higher age.
Another important methodological limitation of our study
involves the fact that only motor NSS were examined. Motor NSS
are generally considered to be of particular importance (5) and can
be easily applied (2). Likewise, Kodama et al. (35) demonstrated
significant age effects only for the motor NSS cited above and
vibration sense of the lower limbs but not for other sensory NSS.
As hypothesized, our investigation of two large birth cohorts
confirmed increased NSS scores in patients with mild AD but not
patients with MCI. According to our findings, NSS do not appear
to be the sequelae of healthy aging since the two birth cohorts
examined showed only minor, non-significant differences with
respect to NSS. That NSS were found to be significantly associ-
ated with executive dysfunction corresponds to earlier studies in
patients with schizophrenia. However, NSS are not only a marker
of brain damage in AD but also reflect aspects of cognitive reserve.
Longitudinal studies are necessary to establish the stability of NSS
in aging, their prognostic value in MCI and – ultimately – to
determine norm values for NSS. From a clinical standpoint, NSS
should be considered as a reliable and easy to administer tool in
the routine examination of patients with cognitive decline.
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